Concepedia

Andreas Gravius

AG

Statistics

Publications

19

Citations

862

H-Index

18

Active since

2005

Affiliations

MerLion Pharma (Germany)(Current)

University of Tübingen

Maj Institute of Pharmacology

First Pavlov State Medical University of St. Petersburg

Polish Academy of Sciences

Andreas Gravius is an author at MerLion Pharma (Germany) specializing in neuroscience, neuropharmacology, and pharmacology.

Publications per year

2005–2018

19

Publications

19

Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats

M. Pietraszek, Piotr Maciejak, Janusz Szyndler et al. · European Journal of Pharmacology · 2005 · 108 citations

, , +11

mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition

M. Pietraszek, Andreas Gravius, D. Schäfer et al. · Neuropharmacology · 2005 · 83 citations

, , +8

The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning

W. Jacob, Andreas Gravius, M. Pietraszek et al. · Neuropharmacology · 2009 · 63 citations

, , +11

Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour

Nico Wegener, Jens Nagel, Ralph Gross et al. · Neuroscience Letters · 2011 · 63 citations

, , +7

The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats – a comparison

Andreas Gravius, Caroline Barberi, D. Schäfer et al. · Neuropharmacology · 2006 · 59 citations

, , +14

1–5 of 19